Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
K-haler versus Symbicort Turbohaler inhaler handling study in asthma, ACOS, or COPD
2014-004564-38Phase 3Completed
- Sponsor
- Mundipharma
- Start
- Mar 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of fluticasone propionate + formoterol and budesonide + formoterol in asthma, Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome (ACOS) and chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Mundipharma. Started Mar 2015; status: completed.
02
Drugs
fluticasone propionate + formoterolbudesonide + formoterol
03
Conditions
asthmaAsthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome (ACOS)chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2014-004564-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004564-38.